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The Journal of Immunology
Monocyte Subsets Coregulate Inflammatory Responses by
Integrated Signaling through TNF and IL-6 at the Endothelial
Cell Interface
Myriam Chimen,* Clara M. Yates,* Helen M. McGettrick,† Lewis S. C. Ward,†
Matthew J. Harrison,* Bonita Apta,* Lea H. Dib,* Beat A. Imhof,‡ Paul Harrison,†
Gerard B. Nash,* and G. Ed Rainger*
Two major monocyte subsets, CD14+CD162 (classical) and CD14+/dimCD16+ (nonclassical/intermediate), have been described.
Each has different functions ascribed in its interactions with vascular endothelial cells (EC), including migration and promoting
inflammation. Although monocyte subpopulations have been studied in isolated systems, their influence on EC and on the course
of inflammation has been ignored. In this study, using unstimulated or cytokine-activated EC, we observed significant differences
in the recruitment, migration, and reverse migration of human monocyte subsets. Associated with this, and based on their patterns
of cytokine secretion, there was a difference in their capacity to activate EC and support the secondary recruitment of flowing
neutrophils. High levels of TNF were detected in cocultures with nonclassical/intermediate monocytes, the blockade of which
significantly reduced neutrophil recruitment. In contrast, classical monocytes secreted high levels of IL-6, the blockade of which
resulted in increased neutrophil recruitment. When cocultures contained both monocyte subsets, or when conditioned supernatant
from classical monocytes cocultures (IL-6hi) was added to nonclassical/intermediate monocyte cocultures (TNFhi), the activating
effects of TNF were dramatically reduced, implying that when present, the anti-inflammatory activities of IL-6 were dominant
over the proinflammatory activities of TNF. These changes in neutrophil recruitment could be explained by regulation of
E-selectin on the cocultured EC. This study suggests that recruited human monocyte subsets trigger a regulatory pathway of
cytokine-mediated signaling at the EC interface, and we propose that this is a mechanism for limiting the phlogistic activity
of newly recruited monocytes. The Journal of Immunology, 2017, 198: 000–000.
P
eripheral blood monocytes play an important role in the
innate immune response against invading pathogens.
However, monocytes and cells that differentiate from them
in inflamed tissues are also involved in the pathogenesis of a
number of diseases (1). A classic example of their contribution to
pathogenesis is seen in atherosclerosis, where monocytes recruited
to the arterial intima differentiate into proinflammatory “foam
cells” upon assimilating cholesteryl ester into storage vesicles (2,
3). Other studies highlight the major role of monocyte-derived
macrophages in the pathogenesis of chronic inflammatory dis-
eases. In the autoimmune disease rheumatoid arthritis the fre-
quency of monocytes is increased in the blood and in the diseased
synovium of the joint, and there is good evidence that these may
contribute to joint destruction (4, 5). The contributions of these
cells to pathogenesis occur after the recruitment of monocytes and
their differentiation into macrophages; however, there is substan-
tial evidence demonstrating that newly recruited monocytes pos-
sess strong phlogistic capabilities and can stimulate endothelial
cells (EC), thereby promoting the secondary recruitment of in-
flammatory leukocytes from the blood (6, 7). Indeed, it appears
that in patients with peripheral vascular disease, circulating blood
monocytes are more aggressively proinflammatory in such assays,
when compared with the monocytes of age-matched heathy con-
trol individuals (8).
Interpretation of the above studies is however problematic, as
they do not consider the differential functions of the monocyte
subpopulations that can readily be demonstrated within the blood.
Monocytes are heterogeneous in terms of size and granularity, but
specific populations are usually defined by the differential ex-
pression of cell surface markers. Human monocytes can be divided
into three main subsets based on the expression of CD14 (the LPS
coreceptor) and CD16 (FCgRIII): CD14+CD162 are often termed
classical monocytes; CD14+CD16+ are intermediate monocytes;
and CD14dimCD16++ are nonclassical monocytes (9). These
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subsets represent 80–95, 2–11, and 2–8% of the circulating pool,
respectively (1, 10–12). Although the rarity of CD16+ subsets, in
particular nonclassical cells, makes them extremely difficult to
analyze functionally, there is evidence that monocyte subsets do
possess distinct functional attributes (1, 12). For example, CD162
and CD16+ monocytes are transcriptionally distinct, with .250
genes being differentially expressed (13, 14). This leads to marked
differences in functions such as phagocytosis and Ag presentation,
and it influences the direction of polarization during differentiation
into macrophages or dendritic cells (13, 15–17). In the context of
inflammation, simple assays measuring the production of cytokines
from isolated monocytes show differences in the production of
TNF, IL-6, IL-1b, and IL-10, depending upon the subset analyzed
(2, 18). The differential expression of chemokine receptors may
also influence the migration responses of monocyte subsets. Clas-
sical monocytes express high levels of CCR2 and migrate more
efficiently to CCL2 in vitro than do other monocyte subsets (19).
Additionally, the fractalkine receptor, CX3CR1, is highly expressed
on intermediate monocytes and has been reported to preferentially
support the migration of this subset across EC overexpressing
superphysiological levels of CX3CL1 (19).
In the context of vascular disease, functionally distinct monocyte
populations are of importance, as the proportional representation of
different subsets in the blood is known to vary in a disease-specific
manner (1, 12). However, studies using monocyte subsets in inte-
grated models of vascular inflammation, where they promote EC
activation and support the secondary recruitment of leukocytes,
have not been reported. To our knowledge, in this study we provide
the first such analysis. In our studies, we have compared classical to
nonclassical/intermediate monocytes grouped together. This is be-
cause the low numbers of isolated intermediate and nonclassical
monocytes did not allow appropriate functional testing of these
subsets individually in our assays. In this study, we describe pat-
terns of recruitment and inflammatory function that are dependent
on the monocyte subset being assayed, and we also identify a
previously unsuspected process of cytokine-mediated regulation of
EC activation by monocytes subsets, which moderates the levels of
secondary leukocyte recruitment on the endothelium.
Materials and Methods
Isolation and culture of human monocytes and monocyte
subsets
Blood samples were obtained in EDTA from healthy donors with written
informed consent and approval from the University of Birmingham Local
Ethical Review Committee (ERN_12-0079C). PBMC and polymorpho-
nuclear neutrophils (PMN) were isolated using Histopaque 1077 and 1119
density media (Sigma-Aldrich, Poole, U.K.) gradient separation (20).
Unfractionated or mixed monocytes were isolated from PBMC by positive
selection using CD14 microbeads and MACS separation columns (Miltenyi
Biotec, Surrey, U.K.). For isolation of classical monocytes, PBMC were
depleted of CD16+ cells using CD16 microbeads and a MACS sep-
aration column (both Miltenyi Biotec) (20). Depleted cells were then
enriched for CD14+ monocytes using CD14 microbeads (Miltenyi Biotec).
Nonclassical/intermediate monocytes were isolated from PBMC using a
CD16+ monocyte isolation kit (Miltenyi Biotec) including incubation with
a nonmonocyte depletion mixture that removes CD15+ and CD56+ cells in
the presence of FCgR blocking Ab. Following this, monocytes were
enriched for CD16+ monocytes using CD16 microbeads. Purity for both
subsets was measured and was routinely 95% for both subsets. Purified
cells were cultured in M199 (Life Technologies, Paisley, U.K.) containing
10 ng/ml epidermal growth factor (Sigma-Aldrich) and 10% autologous
human serum. Monocytes were characterized by surface expression of
CD14 and CD16 (Fig. 1A).
EC isolation and culture
Human umbilical cords were obtained from the Human Biomaterials Re-
source Centre (University of Birmingham; ethics 09/H1010/75), who
collected fully consented tissue from the Birmingham Women’s Hospital
National Health Service Trust. Human umbilical vein EC (HUVEC) were
isolated from umbilical cords as previously described (21) and cultured in
M199 supplemented with 20% FCS, 10 ng/ml epidermal growth factor,
35 mg/ml gentamicin, 1 mg/ml hydrocortisone (all from Sigma-Aldrich),
and 2.5 mg/ml amphotericin B (Life Technologies Invitrogen Compounds).
HUVEC were grown to confluence in 25-cm2 culture flasks (BD Falcon,
Oxford, U.K.) precoated with 1% gelatin solution (Sigma-Aldrich). For the
monocyte static adhesion and transmigration time-course experiments,
primary blood microvascular EC were purchased from PromoCell, cul-
tured in the manufacturer’s recommended medium (EC growth medium;
PromoCell), and passaged up to four times prior to use in experiments (20).
Adhesion assay under static conditions
Confluent primary HUVEC and blood microvascular EC were dissociated
using trypsin/EDTA (Sigma-Aldrich) and seeded on 24-well tissue culture
plates (Falcon; Becton Dickinson Labware). Seeding density was chosen to
yield confluent monolayers within 24 h. TNF (100 U/ml; Sigma-Aldrich)
and IFN-g (10 ng/ml; PeproTech, London, U.K.) were added to confluent
monolayers for 4 or 24 h before adhesion assay with monocytes.
Prior to addition of monocytes, EC were washed twice with M199/0.15%
BSA to remove residual cytokine. Culture dishes were placed on the stage of
a phase-contrast video microscope in a 37˚C enclosure. Isolated monocytes
(1 3 105 in 300 ml) were added to EC for 7 min and allowed to adhere.
Nonadherent cells were gently washed three times with M199/BSA to
remove nonadherent cells, and 8–10 fields of view were acquired at 10 min
and up to 90 min after adhesion using digital phase-contrast microscopy.
Images were analyzed offline using ImagePro software (DataCell,
Finchampstead, U.K.). Monocytes in each field were counted. Average cell
counts were converted to counts per square millimeters multiplied by the area
of the well, divided by the total number of monocytes added, and then mul-
tiplied by 100 to express monocyte adhesion as a percentage of the cells added.
Adherent monocytes were divided into two populations: (1) phase bright cells
on the surface of the EC, and (2) phase dark cells, which had transmigrated
across the EC monolayer (22, 23).
Stimulation of EC by monocyte coculture and PMN adhesion
assay in flow conditions
Mixed monocytes or purified classical and nonclassical/intermediate
monocytes were seeded onto the inside of porous polyethylene tere-
phthalate culture plastic inserts (Beckton Dickinson), which had been
treated with 4% BSA to ensure cell adhesion. The membranes on the inserts
had an effective culture area of 0.3 cm2, a pore size of 0.4 mm, and a pore
density of 1 3 108/cm2. Cells were cultured at a density of 0.5 3 105 cells
per insert in 24-well plates (Becton Dickinson). Monocytes were allowed
to settle on the filters for 45 min, following which confluent HUVEC were
seeded (0.5 3 105 EC) onto the apical side of the filter precoated with 1%
gelatin. Cells were cocultured together for 24 h. In some experiments, rIL-6
(1 ng/ml; PeproTech), a neutralizing Ab against either IL-6 (10 mg/ml; clone
6708) or a function-blocking Ab against TNF (10 mg/ml; clone 1852; all
from R&D Systems), was added when cocultures were established and were
present throughout the coculture. In some experiments, supernatants of
previous cocultures of classical monocytes with EC were added to fresh
cocultures of nonclassical/intermediate monocytes with EC and vice versa.
Viability of isolated monocyte subsets was assessed using calcein-AM
(5 mg/ml; Cambridge Bioscience, Cambridge, U.K.) and trypan blue
(0.2%; Sigma-Aldrich). We found that all adhered monocytes were calcein
positive, and no trypan blue–stained monocytes were detected for either
subset in culture after 45 min or coculture after 24 h. Moreover, the
number of adherent cells of either subset was not significantly reduced
during the 24-h coculture period (Supplemental Fig. 1).
Inserts were incorporated into a parallel plate flow-based adhesion assay
as previously described (18, 24). HUVEC on the apical side of the filter
formed the base of the channel over which PBS containing 0.15% BSA
(PBSA) or isolated, calcein-AM (5 mg/ml; Cambridge Bioscience)–labeled
PMN were perfused at a concentration of 1 3 106/ml at a wall shear stress
of 0.1 Pa (1 dyne/cm2) for 4 min. Following a 2-min wash with PBSA,
cells were illuminated with a blue laser (488 nm) and five random fields
were acquired using fluorescence microscopy (Andor Technology, Belfast,
U.K.), and total leukocyte recruitment (per mm2/106 cells perfused) was
analyzed and calculated off-line using ImagePro Plus software.
Analysis of secreted cytokines and chemokines
Luminex kits were purchased from Merck Millipore (Billerica, MA), and
the experiment was performed on cell culture supernatants according to the
manufacturer’s instructions. Data were collected and analyzed using a
Luminex 100 machine (Luminex, Austin, TX).
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Analysis of protein expression by flow cytometry
Isolated monocytes were incubated with Abs against CD14 (1:100 CD14–
eFluor 450, clone 61D3; eBioscience) or CD16 (1:100 CD16-PE-Cy7,
clone eBioCB16; eBioscience) or appropriate isotype controls for
30 min at 4˚C. Plated HUVEC were labeled with Abs against E-selectin
(1:100 PE conjugated, clone 68-5H11), VCAM-1 (1:100 FITC conju-
gated, clone 51-10C9), or ICAM-1 (1:200 allophycocyanin conjugated,
clone HA58; all from BD Biosciences) for 30 min at 4˚C. Cells were
collected using Accutase (Sigma-Aldrich) for 2 min at 37˚C and wells
were washed with M199 containing 10% FCS. Cells were then washed in
0.15% PBSA and fixed for 5 min in 2% paraformaldehyde. Surface ex-
pression was analyzed by flow cytometry on a Dako CyAn (Beckman
Coulter, High Wycombe, U.K.), and data were analyzed using Summit
software (Dako).
Analysis of gene expression by quantitative PCR
Total mRNAwas extracted using the RNAeasy mini kit (Qiagen, Crawley,
U.K.) according to the manufacturer’s protocol. Briefly, EC were collected
from the Transwell coculture filters using Accutase, lysed, and then added
to a column. After three washes, mRNA was eluted from the column with
water. mRNA concentration was measured using a NanoDrop spectrofluo-
rometer (LabTech) and mRNA was stored at 280˚C. To convert mRNA to
cDNA, random primers (Promega) were annealed to 1 mg of mRNA for
5 min at 70˚C, after which the following mastermix was added to give a final
volume of 30 ml: 10 U of SuperScript II reverse transcriptase, 10 U of
RNaseOUT, 13 SuperScript buffer (all from Invitrogen) and 10 mM dNTPs
(Promega). The reaction was run at 37˚C for 1 h, followed by 5 min at 95˚C.
To analyze mRNA, FAM-labeled E-selectin and suppressor of cytokine
signaling (SOCS)3 primers and VIC-labeled 18S primers were bought as
Assays-on-Demand kits from Applied Biosystems (Warrington, U.K.).
Samples were amplified in duplicates using the 7500HT real-time PCR
machine (Applied Biosystems) and analyzed using the software package
SDS 2.2 (Applied Biosystems). Data were expressed as relative expression
units relative to 18S or as fold change (22DDCt method).
Statistical analysis
Differences were analyzed using GraphPad Prism software (GraphPad
Software, La Jolla, CA) by a paired or unpaired t test to analyze differences
between classical and nonclassical/intermediate monocytes. One- or two-
way ANOVA followed by a Bonferroni post hoc analysis for multiple
group comparison was used to compare the different conditions within a
monocyte subset. Normality was checked using the Kolmogorov–Smirnov
test. A p value #0.05 was considered significant.
Results
The behavior of monocytes upon recruitment is
subset-dependent
Migration of monocytes into tissue occurs under both steady-state
and inflammatory situations, and this has largely been studied
in vivo using mouse models (25–31). In experiments using human
monocytes there are limited data indicating differences in the
migration of subsets on unstimulated EC monolayers (28). How-
ever, the specific patterns of adhesion, transmigration, and reverse
transmigration of the subsets in inflammatory conditions remains
unclear. In this study we compared the behavior of classical and
nonclassical/intermediate monocytes subsets during 90 min on
unstimulated EC or monolayers subjected to different regimens of
inflammatory activation (i.e., 4 h TNF, 24 h TNF, 24 h TNF plus
IFN-g). Under all conditions, classical monocytes were signifi-
cantly more efficient at adhering to EC than were nonclassical/
intermediate monocytes (Fig. 1B).
Upon analyzing the efficiency of migration we found quite
distinct patterns that were dependent on monocyte subset. After
10 min of adhesion, ∼40% of nonclassical/intermediate monocytes
had undergone transendothelial migration, and this did not sig-
nificantly increase during the ensuing 90 min, with the levels of
transmigrated nonclassical/intermediate monocytes remaining
constant throughout the experiment (Fig. 1C, 1D). In contrast,
significantly fewer classical monocytes had undergone trans-
endothelial migration after 10 min (20%). However, the number
of migrated cells continued to rise to a maximum of 80% at
50 min, which was significantly greater than the efficiency of
migration of nonclassical/intermediate monocytes (Fig. 1C, 1D).
Most interestingly, we observed that although migrated nonclassical/
intermediate monocytes remained under the EC monolayer for the
duration of the experiment, classical monocytes underwent reverse
transmigration, so that by 90 min 50% of the transmigrated pop-
ulation had moved back to the apical surface of the EC monolayer
(Fig. 1C, 1D).
Differences in TNF secretion regulate the levels of EC
activation by monocyte subsets
We previously demonstrated that unfractionated monocytes stim-
ulate secondary leukocyte recruitment on EC (6, 7). Using a
Transwell coculture model, we investigated the propensity of
classical and nonclassical/intermediate monocyte subsets to in-
duce neutrophil adhesion on cocultured EC.
In the absence of exogenous cytokines, EC that were cultured on
Transwell inserts in the absence of monocytes did not support the
efficient adhesion of flowing neutrophils (Fig. 2A, 2B). In contrast,
the coculture of EC with unfractionated monocytes for 24 h, on
the opposite sides of 0.4-mm-pore Transwell membranes, pro-
moted the adhesion of flowing neutrophils (Fig. 2B), consistent
with our previous observations (6, 7). Interestingly, though, when
isolated monocyte subsets were cocultured with EC, nonclassical/
intermediate monocytes could induce significantly higher levels of
neutrophil adhesion than classical monocytes (Fig. 2A, 2B). In-
deed, classical cells, which represent 90% of the circulating
population, stimulated EC to the same extent as unfractionated
monocytes. Importantly, we found that the viability of classical
and nonclassical/intermediate monocytes was unafected after 24 h
of culture, meaning that the differences in EC activation and neu-
trophil recruitment were not based on different numbers of mono-
cytes in coculture (Supplemental Fig. 1). To demonstrate that the
subset isolation procedure had not unduly influenced the inflam-
matory activity of the monocytes, we mixed the isolated subsets at
physiological ratios (90% classical and 10% nonclassical/
intermediate) and observed the same profile of neutrophil adhe-
sion as seen in unfractionated monocytes (Fig. 2B).
Secretion of TNF is the mechanistic pathway by which
unfractionated monocytes have been shown to activate EC (6, 7).
Thus, we tested whether this was also the mechanism by which
fractionated monocytes could stimulate cocultured EC. When we
assayed for the production of this cytokine in coculture superna-
tants, we found that EC alone did not generate detectable levels
(Fig. 2C). Nonclassical/intermediate monocytes in coculture with
EC generated substantial levels of TNF (100 pg/ml) that were
higher than levels in cocultures with classical monocytes or
unfractionated monocytes (Fig. 2C). As neutrophil recruitment
from flow in this model is supported by E-selectin (6, 7), we
verified that this receptor also showed differential expression in
response to EC coculture with the different monocyte subsets. The
expression of both E-selectin mRNA and protein was higher in
nonclassical/intermediate monocyte cocultures and reduced when
TNF was blocked (Fig. 2D, 2E). The dominant role of this cyto-
kine in promoting neutrophil recruitment was confirmed when a
function neutralizing Ab against TNF was added to cocultures.
This resulted in significant reductions in the expression of
E-selectin and the recruitment of flowing neutrophils to EC
cocultured with nonclassical/intermediate monocytes (Fig. 2E,
2F). Although we observed an upregulation of ICAM-1 and
VCAM-1 expressions on HUVEC in coculture with both mono-
cyte subsets compared with EC alone, we did not find differ-
ences in expression on HUVEC cocultures with classical and
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nonclassical/intermediate monocytes at either the mRNA (Fig. 3A,
3B) or protein (Fig. 3C, 3D) levels.
IL-6 generated by classical monocytes regulates EC activation
We have previously demonstrated that IL-6 contributed to the
reduction in leukocyte adhesion when EC were cultured in direct
contact with mesenchymal stem cells or in close proximity to fi-
broblasts (32, 33). Upon analysis of the profile of cytokine se-
cretion in coculture supernatants, we observed that IL-6 was also
differentially released by monocyte subsets cocultured with EC
(Fig. 4A). Classical monocyte cocultures produced significantly
higher concentrations of IL-6 compared with nonclassical/
intermediate monocytes. As we have previously shown that IL-6
can regulate neutrophil trafficking in coculture experiments (32),
we neutralized its activity and assayed for the recruitment of
flowing neutrophils. Neutralizing IL-6 in cocultures containing
classical cells led to a significant increase in the level of neutrophil
recruitment compared with untreated cocultures (Fig. 4B), im-
plying that IL-6 was operating as a functional break on endothelial
responses to TNF. As IL-6 was operating in an autocrine fashion
in cocultures of classical monocytes and EC, we used rIL-6 to
determine whether we could regulate neutrophil recruitment in
nonclassical/intermediate monocyte–based cocultures in a para-
crine fashion. Using a concentration consistent with that produced
FIGURE 1. Comparative adhesion and migration of classical and nonclassical/intermediate monocytes on EC. (A) Levels of expression of CD14 and
CD16 on circulating monocytes and subsets isolated from PBMC measured by flow cytometry (plots representative of .10 preparations). (B) Total ad-
hesion of monocyte subsets on unstimulated EC or EC treated with cytokines (n = 3–4). (C) Representative images of monocyte subsets adhered and
transmigrated across unstimulated and TNF stimulated EC. Original magnification 3100. (D) Time course of transmigration of monocytes across
TNF-stimulated EC (n = 3). Data are mean 6 SEM. *p # 0.05, **p # 0.01 using a two-ANOVA and Bonferroni posttest (B) and comparison between
classical and nonclassical/intermediate monocytes using a two-way repeated measures ANOVA and Bonferroni posttest (D). C, classical monocyte; NC/I,
nonclassical/intermediate monocyte.
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by classical monocyte cocultures (1 ng/ml), we could dramati-
cally reduce neutrophil recruitment in nonclassical/intermediate
monocyte cocultures upon the addition of exogenous IL-6
(Fig. 4C). Importantly, this was predicated on regulation of
E-selectin expression, which was dramatically upregulated on
EC cocultured with classical monocytes in the presence of IL-6
blockade (Fig. 4D).
Having demonstrated that IL-6 could function to regulate neu-
trophil trafficking in a paracrine fashion in our model, we tested
whether crosstalk between monocyte subsets occurred through
their secreted cytokines. Importantly, we observed no other dif-
ferences in levels of secreted cytokines (such as IL-1b, IL-4,
CXCL8, IL-10, CXCL10, CCL2, LTa, Flt3L, CX3CL1, GM-CSF,
CXCL1, or CCL3) in the cocultures measured using a multiplexed
immunofluorometric assay (Supplemental Fig. 2). Using the con-
ditioned supernatants from monocyte subset–specific cocultures, we
conducted a number of supernatant crossover experiments. The
addition of matched supernatants to monocyte subset cocultures
(i.e., classical to classical or nonclassical/intermediate to nonclassical/
intermediate monocytes) did not affect patterns of neutrophil
FIGURE 2. Comparative abilities of classical and nonclassical/intermediate monocyte subsets to activate EC: role of TNF. (A) Representative images of
neutrophils adhered from flow on EC in coculture with monocyte subsets for 24 h (n = 3). Original magnification 3200. (B) Recruitment of neutrophils
from flow on EC in coculture with monocyte subsets (Mix monocytes indicates unfractionated monocytes; classical plus nonclassical/intermediate
monocytes indicates 90% classical plus 10% nonclassical/intermediate monocytes) for 24 h (n = 3). (C) Concentration of TNF-a (picograms per milliliter)
in supernatants of monocyte subsets in coculture with EC for 24 h measured using a Luminex assay (n = 3). (D) mRNA expression of E-selectin on EC
alone or in coculture with monocyte subsets for 24 h (n = 7–9). (E) Surface expression of E-selectin on EC following coculture with monocyte subsets for
24 h, measured by flow cytometry (n = 4–5). TNF was neutralized using an Ab at 10 mg/ml during the 24-h coculture with nonclassical/intermediate
monocytes. Data were normalized to expression of E-selectin on EC alone. (F) Recruitment of neutrophils from flow on EC cocultured with monocyte
subsets for 24 h, with or without 10 mg/ml anti-TNFAb (n = 3). Data are mean6 SEM from n experiments. *p# 0.05, **p# 0.01, ***p# 0.001 comparison
between classical and nonclassical/intermediate monocytes using repeated measures ANOVA and a Bonferroni posttest (A), ANOVA and a Bonferroni posttest
(B, C, and E), an unpaired t test (D), and a two-way ANOVA and a Bonferroni posttest (F). C, classical monocyte; NC/I, nonclassical/intermediate monocyte.
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recruitment (Fig. 4E). The addition of nonclassical/intermediate
monocyte supernatant (TNFhi/IL-6lo) to classical monocyte co-
cultures (TNFlo/IL-6hi) did not increase neutrophil recruitment
(Fig. 4E). Interestingly, the addition of classical (TNFlo/IL-6hi)
coculture supernatants to nonclassical/intermediate monocytes
(TNFhi/IL-6lo) cocultures abolished neutrophil recruitment (Fig.
4E). Importantly, both of these experimental outcomes show that
IL-6 is the dominant functional cytokine and downregulates the
TNF response when it is present. This was confirmed when high
levels of neutrophil adhesion were restored on nonclassical/
intermediate monocytes cocultures in the presence of classical
coculture supernatant treated with an IL-6 function neutralizing
Ab (Fig. 4E).
Recent studies have indicated that IL-6–mediated regulation of
the transcription factor SOCS3, which is a negative regulator of
the JAK/STAT signaling pathway, can downregulate expression
of proinflammatory genes in EC, including E-selectin, thereby
influencing leukocyte trafficking responses (34). In this study, we
found that in the presence of classical monocytes (and thus high
IL-6) there was high EC expression of SOCS3 mRNA (Fig. 4F). In
contrast, in the presence of nonclassical/intermediate monocytes
(low IL-6), EC showed a much lower expression of SOCS3
mRNA (Figs. 4F, 5).
Discussion
We have previously demonstrated that in coculture, a mixed
population of monocytes can activate EC, leading to the recruit-
ment of flowing neutrophils (6, 7). In this study, we extended these
observations using monocyte subsets and have identified, to our
knowledge for the first time, a differential ability of classical and
nonclassical/intermediate monocyte subsets to activate EC
(Fig. 5). To our knowledge, we first demonstrated that monocyte
subsets behave differently in terms of recruitment, transmigration
and reverse transmigration on EC. Indeed, we have shown that
more classical monocytes are recruited on both unstimulated and
cytokine-stimulated EC, which is in agreement with other pub-
lished data (28). Although the efficiency of migration of
nonclassical/intermediate monocytes was low (40%), those cells
that did migrate traversed the monolayer rapidly, remaining un-
derneath for the duration of the experiment. In contrast, classical
cells continued to migrate for 50 min, leading to an efficiency
of migration in .80%. Interestingly, nonclassical/intermediate
monocytes did not possess the capacity to reverse transmigrate
similar to classical monocytes. The physiological relevance of
reverse migration is still unclear; however, this process has now
been observed for neutrophils, lymphocytes, and monocytes both
in vitro and in vivo (16, 26, 35–37). Thus, it is interesting that the
nonclassical/intermediate monocytes do not undertake this be-
havior. This implies lack of appropriate receptors to respond to
signals for reverse migration, or alternatively possession of re-
ceptors that respond to retention signals within the subendothelial
environment.
As nonclassical/intermediate monocytes are not able to return to
the circulation under inflammatory conditions, this raises the issue
of their potential capacity to influence EC activation. Our model of
monocyte coculture with EC allowed us to investigate processes
that may occur in the microcirculation during inflammation or in
the artery wall during atherogenesis. In these conditions, mono-
cytes are efficiently recruited (2, 38) and can activate EC to recruit
more leukocytes (6, 7). In agreement with published observations
on the surface expression of markers and cytokine expression in
monocyte subsets (12), we observed a higher capacity of
nonclassical/intermediate monocytes to secrete TNF and higher
secreted levels of IL-6 in classical monocytes. We show that
nonclassical/intermediate monocytes are able to efficiently acti-
vate EC to recruit circulating neutrophils because of their capacity
FIGURE 3. Expression of VCAM-1 and ICAM-1 in EC in coculture with monocyte subsets. (A and B) mRNA expression of VCAM-1 (A) and ICAM-1
(B) on EC in coculture with monocyte subsets for 24 h (n = 7–9). (C and D) Surface expression of VCAM-1 (C) and ICAM-1 (D) on EC following coculture
with monocyte subsets for 24 h, measured by flow cytometry (n = 4–5). Data are normalized to classical monocyte mean fluorescence intensity (MFI). Data
are mean 6 SEM from n experiments. *p # 0.05, **p # 0.01, NS, not significant using unpaired t test (A and B) and ANOVA and a Dunnet posttest to EC
alone (C and D). C, classical monocyte; NC/I, nonclassical/intermediate monocyte.
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to secrete TNF, which upregulates the expression of E-selectin on
EC allowing efficient capture of flowing neutrophils. In contrast,
classical monocytes are able to secrete IL-6, which downregulates
the expression of E-selectin on EC via induction of SOCS3,
thereby reducing neutrophil recruitment.
Other studies have shown different expression of surface markers
and cytokine profiles on nonclassical and intermediate monocytes
as well as different phagocytosis, Ag processing and presentation,
proangiogenic and patrolling behaviors, and proportions in diseases
(reviewed in Ref. 39). In our studies, we are not able to attribute
the effects of nonclassical/intermediate monocytes to a more
specific subpopulation due to limited material available. Indeed,
isolation of intermediate nonclassical and intermediate monocytes
is not achievable using magnetic beads to date. Moreover, the
numbers of either subset are limiting when they are further sub-
divided. Indeed, even using pooled nonclassical/intermediate
monocytes, we were at the limit of functionality in our cocul-
ture assays when making multiple comparisons. A more detailed
FIGURE 4. Role of IL-6 in regulating EC activation by monocyte subsets. (A) Concentration of IL-6 (picograms per milliliter) in supernatants of
monocyte subsets in coculture with EC for 24 h measured using a Luminex assay (n = 3). (B) Recruitment of neutrophils from flow on EC cocultured with
classical monocytes, with or without neutralizing Ab against IL-6 (10 mg/ml) (n = 4). (C) Recruitment of neutrophils on EC cocultured with nonclassical/
intermediate monocytes, with or without rIL-6 (1 ng/ml) (n = 4). (D) Surface expression of E-selectin on EC following coculture with monocyte subsets for
24 h, measured by flow cytometry. Data were normalized to expression of E-selectin on cocultures with classical monocytes (n = 4–5). (E) Recruitment of
neutrophils from flow on EC cocultured with monocyte subsets for 24 h: effect of adding supernatants from cocultures with either subset, and of neu-
tralizing Ab against IL-6 (10 mg/ml) (n = 3). (F) mRNA expression of SOCS3 on EC alone or in coculture with monocyte subsets for 24 h (n = 7–9). Data
are shown as mean 6 SEM. *p # 0.05, ***p # 0.001, ****p # 0.0001, comparison between classical and nonclassical/intermediate monocytes using an
unpaired t test (D and F), a paired t test (B and C), and ANOVA and a Bonferroni posttest (A and E). C, classical monocyte; NC/I, nonclassical/intermediate
monocyte; PMN, polymorphonuclear neutrophil.
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analysis would be of great interest, but to conduct these in ex-
acting multicellular systems is going to prove extremely de-
manding from a technical point of view. Indeed, this probably
explains the extremely limited data available on the function of
these two subsets.
It is clear that TNF is a proinflammatory mediator able to induce
the expression of E-selectin on EC and promote leukocyte re-
cruitment (6). Although IL-6 is often termed an inflammatory
cytokine, it does not drive leukocyte recruitment per se (33).
Rather, previous studies have shown the ability of IL-6 either
alone or in conjunction with TGF-b1 to modify inflammatory
infiltrates by inhibiting recruitment (40, 41) or by switching re-
cruitment from neutrophils to mononuclear leukocytes (42–44). In
this context, we have reported that the inhibitory actions of IL-6
are also exploited by Kaposi’s sarcoma herpesvirus to reduce
neutrophil migration (34). Indeed, we have also shown that IL-6
alone, or in combination with TGF-b1, was responsible for the
immunosuppressive effects of glomerular podocytes (45), mes-
enchymal stem cells (32, 46), and healthy dermal fibroblasts (33).
In these in vitro studies, leukocyte adhesion to inflamed endo-
thelium was reduced in the presence of IL-6. In contrast, stromal
cells from chronically inflamed sites, such as the rheumatoid joint
or atherosclerotic plaque, transform the bioactivity of IL-6 and/or
TGF-b1, making them act in a stimulatory (47) or proin-
flammatory manner (33, 48). Consequently, the mode of action of
IL-6 is contextual, defined by other cofactors present within the
local milieu (49). Thus, in healthy conditions it is likely that
classical monocyte–derived IL-6 controls the magnitude of the
inflammatory response by limiting access of other leukocytes, and
this may favor resolution of the inflammatory process. Although
IL-6 can act in concert with TGF-b1 to mediate its immunosup-
pressive effects (32, 33, 41, 46), this also appears to be context
specific, with IL-6 able to act in an anti-inflammatory manner,
independent of TGF-b1 (34, 45, 50). In our model, blockade of
TGF-b1 in monocyte subsets in coculture with EC did not alter
neutrophil recruitment (data not shown), suggesting that IL-6 is
acting through another mechanism of action to regulate TNF
signaling. Our work indicates a role for SOCS3 in the IL-6–
modulated responses of EC to TNF, in particular regulation of
E-selectin on EC. The SOCS family consists of eight structurally
related proteins that are induced by different cytokines and other
stimuli (51) and attenuate signaling by blocking JAK tyrosine kinase
activity or STAT activation (51). In our study, SOCS3 is expressed at
low levels in unstimulated EC and is significantly upregulated on EC
in coculture with classical monocytes (IL-6hi/TNFlo). Supporting the
idea that SOCS3 can have a role in the modulation of neutrophil
recruitment during inflammation, IL-1–induced acute inflammatory
arthritis was particularly severe in SOCS3 knockout mice (52), a
model characterized by increased numbers of neutrophils in the
inflamed synovium. Taken together, these data support the idea that
SOCS3 is initially upregulated by IL-6 and in turn suppresses sig-
naling of other mediators, such as TNF and IL-1. Indeed, this idea is
FIGURE 5. Cytokines secreted by monocyte subsets balance EC activation. Nonclassical/intermediate monocytes generate high levels of TNF once in
proximity with EC, which causes upregulation of E-selectin expression at the EC surface. This in turn promotes secondary leukocyte recruitment. In normal
inflammatory conditions, classical monocytes regulate the extent of nonclassical/intermediate monocyte–induced EC activation by secreting IL-6, which
reduces surface expression of E-selectin via upregulation of SOCS3, a negative regulator of the JAK/STAT signaling pathway. In disease, potential changes
in classical and nonclassical/intermediate monocyte recruitment may alter the balanced control of inflammation mediated by the regulation mediated by
both subsets. C, classical monocyte; NC/I, nonclassical/intermediate monocyte.
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supported by a previous study that showed that SOCS3 over-
expression in a colon cancer cell line inhibits subsequent TNF-
induced p65 phosphorylation (53). This was also shown in EC in
which the Kaposi’s sarcoma–associated herpesvirus inhibits TNF
induced neutrophil migration by upregulating IL-6 release, which in
turns activates SOCS3 (34).
Differential cytokine-mediated regulation of EC activation by the
monocyte subsets in an inflammatory environment is a novel obser-
vation. We show that supernatants with high levels of IL-6 from
classical monocyte cocultures with EC are able to downregulate
nonclassical/intermediate monocyte inflammatory responses driven by
TNF. In contrast, nonclassical/intermediate monocyte supernatants
rich in TNF were not able to counteract the anti-inflammatory
properties of IL-6 in classical monocyte cocultures. Thus it seems
likely that in the context of physiological resolving inflammation, rapid
responses to inflammatory stimuli can be mediated by nonclassical/
intermediate monocytes, as they are able to transmigrate rapidly
and efficiently across the endothelium. However, subsequent re-
cruitment of classical cells would control the extent of such a response,
as these IL-6–secreting cells become represented in the inflammatory
infiltrate. In the context of chronic disease where the ratio of the
subsets may be skewed toward nonclassical/intermediate monocytes,
one might predict a bias to prolonged or exaggerated inflammatory
responses that could contribute to the development of disease. Indeed,
such a scenario is reported in pathological conditions such as sepsis
(54), tuberculosis, metastatic cancer, asthma (55), and HIV infection
(17) as well as coronary heart disease (56). Thus, manipulating the
abundance and biological activity of monocyte subsets may have
utility in moderating pathogenesis in a number of diseases.
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